Toggle light / dark theme

Cannabidiol for musculoskeletal regenerative medicine

It is well-established that chronic MSK pain is the key factor for physical disability in the adult population. 19 The World Health Organization (WHO) estimates that 20–33% (over 1.71 billion individuals) of the global population suffers from chronic MSK pain. 20 This type of disorder is characterized by acute or chronic pain in MSK structures, which involve muscles, tendons, ligaments, bones, and nerves. 21 The most common conditions responsible for visits to a physician’s office are OA, rheumatoid arthritis, myofascial pain syndrome (MPS), and low back and neck pain. 22 Less common incidents are generally accompanying with injuries like of tendon sprains, ligament tears, muscle tears, fractures, and similar damage during sports. 20

If left untreated, these conditions progressively increase suffering, disability, and drug consumption, which subsequently diminish an individual’s quality of life. 23 This also translates to a main community health problem due to significant high expenses for health-care systems and insurance for disability. Advanced age may remain the top variable associated with the increased risk of musculoskeletal disorders (MSDs) and MSK pain; however, these conditions may still unfold at any given age for various reasons. Therefore, every individual is at risk of experiencing MSK pain throughout an entire lifetime. 24 Acute pain can become chronic due to numerous factors. The level of intensity, site, and time of noxious stimuli are dictated by the interplay between mechanical, chemical, and thermal receptors and immune cells. 25 Under standard conditions, noxious stimuli and painful sensations gradually decrease with the progression of healing.

The brain–body energy conservation model of aging

Aging senescent cells do not become hypometabolic.

Instead they become HYPERmetabolic, burning energy faster than their younger selves.

This likely steals energy for other useful cellular functions, possibly accounting for their aberrant behaviors.

As we…


The authors offer a new energy-focused perspective on aging by introducing a brain–body model that positions the brain’s response to cytokine signals of hypermetabolism as a mechanistic link between the cellular hallmarks and organismal manifestations of aging.

Biohacker Bryan Johnson reveals how he ‘reversed hair loss & greying by 70%’

BIOHACKER Bryan Johnson who’s shelling out millions in his quest for immortality has revealed the exact steps he follows to reverse his hair loss and get rid of greys.

The tech-tycoon, 47, claimed he’s been able to grow a full head of hair despite being “genetically bald” through a mix of supplements, red light therapy and customised hair oil.

At one time, Bryan was best known for founding the payments company Braintree — but nowadays he’s making headlines for his very expensive quest to turn back the clock and become 18 again.

Exploring Aging and Aging Interventions with Aubrey de Grey

In this episode of the Longevity Optimization Podcast, Dr. DeGray discusses groundbreaking research in aging and longevity, focusing on combination therapies, the hallmarks of aging, and the potential of stem cell and gene therapies. He emphasizes the importance of rejuvenation over merely slowing aging and explores the role of the immune system in health. The conversation also touches on biological age testing, lifestyle factors, and the future of gene therapy in enhancing longevity.

Aubrey de Grey is a British biomedical gerontologist and the founder of the SENS Research Foundation. He is a leading advocate for regenerative medicine, focusing on reversing the effects of aging by repairing cellular damage. Known for his bold vision of life extension, de Grey believes that with advanced therapies, humans could significantly extend their lifespan. He is the co-author of Ending Aging, and his work continues to shape the future of longevity science.

Takeaways.

Combination therapies are crucial for understanding aging.
Rejuvenation may be easier than slowing down aging.
Stem cell therapies hold great promise for the future.
The immune system plays a significant role in aging.
Biological age testing can provide insights into health.
Gene therapy is a promising avenue for longevity research.
Lifestyle factors have limited impact on lifespan extension.
Understanding the hallmarks of aging is essential for interventions.
Preventative maintenance is key to longevity.
The future of aging research is bright with new technologies.

Chapters.

00:00 Introduction to Longevity and Aging Research.

Synthetic Biology: George Church on Genome Sequencing and De-Extinction

The great George Church takes us through the revolutionary journey of DNA sequencing from his early groundbreaking work to the latest advancements. He discusses the evolution of sequencing methods, including molecular multiplexing, and their implications for understanding and combating aging.

We talk about the rise of biotech startups, potential future directions in genome sequencing, the role of precise gene therapies, the ongoing integration of nanotechnology and biology, the potential of biological engineering in accelerating evolution, transhumanism, the Human Genome Project, and the importance of intellectual property in biotechnology.

The episode concludes with reflections on future technologies, the importance of academia in fostering innovation, and the need for scalable developments in biotech.

00:00 Introduction to Longevity and DNA Sequencing.
01:43 George Church’s Early Work in Genomic Sequencing.
02:38 Innovations in DNA Sequencing.
03:15 The Evolution of Sequencing Methods.
07:41 Longevity and Aging Reversal.
12:12 Biotech Startups and Commercial Endeavors.
17:38 Future Directions in Genome Sequencing.
28:10 Humanity’s Role and Transhumanism.
37:23 Exploring the Connectome and Neural Networks.
38:29 The Mystery of Life: From Atoms to Living Systems.
39:35 Accelerating Evolution and Biological Engineering.
41:37 Merging Nanotechnology and Biology.
45:00 The Future of Biotech and Young Innovators.
47:16 The Human Genome Project: Successes and Shortcomings.
01:01:10 Intellectual Property in Biotechnology.
01:06:30 Future Technologies and Final Thoughts.